Retrosteroidal compounds corresponding to formula I, representing progesterone receptor modulators, and their production, and pharmaceutical preparations containing these compounds. These compounds are useful in the treatment of benign gyne…
Described herein arenew retrosteroidal compounds of general formula (I), representing progesterone receptor modulators, and their production, and pharmaceutical preparations containing these compounds. Saidcompounds are preferably used for …
Retrosteroidal compounds of formula I which act as progesterone receptor modulators, a method for their production, and pharmaceutical preparations containing these compounds. These compounds are preferably used for the treatment of benign …
Described herein are new retrosteroidal compounds of general formula (I), representing progesteronereceptor modulators, and their production, and pharmaceutical preparationscontaining these compounds. Said compounds are preferably used for …
Described herein are new retrosteroidal compounds of general formula (I), representing progesterone receptor modulators, and their production, and pharmaceutical preparations containing these compounds. Said compounds are preferably used fo…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
3,15-substituted estrone compounds which act as inhibitors of 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), salts thereof, pharmaceutical preparations containing such compounds, processes for preparing such compounds, and therap…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing the…